North America Molecular Diagnostics Market Size & Outlook
The molecular diagnostics market in North America is expected to reach a projected revenue of US$ 13,347.1 million by 2030. A compound annual growth rate of 3.6% is expected of North America molecular diagnostics market from 2025 to 2030.
North America molecular diagnostics market highlights
The North America molecular diagnostics market generated a revenue of USD 10,543.3 million in 2024.
The market is expected to grow at a CAGR of 3.6% from 2025 to 2030.
In terms of segment, reagents was the largest revenue generating product in 2024.
Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
Market revenue in 2024
USD 10,543.3 million
Market revenue in 2030
USD 13,347.1 million
Growth rate
3.6% (CAGR from 2025 to 2030)
Largest segment
Reagents
Fastest growing segment
Reagents
Historical data covered
2018 - 2023
Base year for estimation
2024
Forecast period covered
2025 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Instruments, Reagents
Other key industry trends
In terms of revenue, North America region accounted for 40.9% of the global molecular diagnostics market in 2024.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Latin America is the fastest growing regional market and is projected to reach USD 1,718.7 million by 2030.
North America holds the leading position in the global market, driven by the growing adoption of molecular diagnostics, which are valued for their superior accuracy, sensitivity, and specificity. The rising demand for genetic testing, particularly for personalized healthcare in conditions such as diabetes and cancer, is anticipated to fuel market expansion.
Additionally, strategic collaborations between prominent pharmaceutical firms and molecular diagnostic companies aimed at developing companion diagnostics are fostering significant growth opportunities in the region.
North America Molecular Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Molecular Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 69.46% in 2024.
Horizon Databook has segmented the North America molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2030.
North America holds the leading position in the global market, driven by the growing adoption of molecular diagnostics, which are valued for their superior accuracy, sensitivity, and specificity. The rising demand for genetic testing, particularly for personalized healthcare in conditions such as diabetes and cancer, is anticipated to fuel market expansion.
Additionally, strategic collaborations between prominent pharmaceutical firms and molecular diagnostic companies aimed at developing companion diagnostics are fostering significant growth opportunities in the region.
North America Molecular Diagnostics Market Product Outlook (Revenue, USD Million , 2018-2030)
Instruments
Reagents
Others Product
North America Molecular Diagnostics Market Test Location Outlook (Revenue, USD Million , 2018-2030)
Point of care
Self test or OTC
Central laboratories
North America Molecular Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
PCR
ISH
INAAT
Chips and microarrays
Mass spectrometry
Sequencing
TMA
Others Technology
North America Molecular Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
Oncology
Pharmacogenomics
Infectious disease
Genetic testing
Neurological disease
Cardiovascular disease
Microbiology
Others Application
Reasons to subscribe to Molecular Diagnostics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Molecular Diagnostics Market Outlook databook
Our clientele includes a mix of Molecular Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Molecular Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Molecular Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
North America Molecular Diagnostics Market, 2018-2030 (US$M)